Adma Biologics | ADMA - Ebitda

주가
11.26
매일 변경
0.18 1.62%
매월
16.93%
매년
-48.49%
Q2 예상
11.02




Ebitda 변화 날짜
Adma Biologics USD 73.59M 14.85M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Novavax USD 19.36M 190.79M 2025-12
Omeros USD -47.96M 7.39M 2023-09
Takeda JPY 448.13B 173.98B 2025-12